Recently, we produced antipodoplanin (PDPN) cancer-specific mAbs clone LpMab-2(21,22) and LpMab-23,(23,24) which specifically recognize cancer-type PDPN in tumor tissues. This evidence concerns the gene PDPN and neoplasm.